I131VolatilityExtendedChecker

I-131 Volatility Extended Checker — Extended volatile iodine control in iodine-131 capsules

ℹ️  Utility performs DEEP analysis of volatile iodine with:
    • Current value check (≤5.0%)
    • Stability prediction until end of shelf life (60 days)
    • Trend analysis with previous measurements
    • Temperature and humidity storage impact assessment
    • Personnel risk evaluation and specific recommendations

⚠️  CRITICAL: Volatile iodine >5.0% creates radiation hazard for personnel!
    Even 5.1% requires immediate action — iodine sublimes at room temperature,
    creating radioactive vapor cloud when package is opened!

Usage:
  I131VolatilityExtendedChecker.exe                            → demo mode (console output)
  I131VolatilityExtendedChecker.exe input.csv output.json      → analyze your data

Input format:
BatchNumber,VolatileIodinePercent_Current,MeasurementDateTime,ProductionDateTime,StorageTemperatureC,PreviousVolatileIodinePercent,PreviousMeasurementDateTime,HumidityPercent

Examples (optional parameters can be empty):
  I131-VOL-2026-001,2.5,2026-03-18T10:00:00,2026-03-10T08:00:00,22.0,2.3,2026-03-15T10:00:00,45.0
  I131-VOL-2026-002,4.2,2026-03-18T10:00:00,2026-03-01T08:00:00,28.0,3.8,2026-03-10T10:00:00,60.0
  I131-VOL-2026-003,5.8,2026-03-18T10:00:00,2026-03-15T08:00:00,32.0,,,70.0

— WHY IS THIS NEEDED?
Volatile iodine control is CRITICALLY IMPORTANT safety parameter for iodine-131 capsules:
• Volatile iodine (sublimed I-131) creates radiation hazard when package is opened
• Laboratory personnel risk internal exposure through inhalation
• Even minor exceedance (5.1%) requires immediate batch quarantine
• Volatility stability depends on: storage temperature, humidity, capsule integrity, storage time

⚠️  CRITICAL:
• Pharmacopoeial limit: ≤5.0% volatile iodine (USP <823>, Ph. Eur. 2.14.1)
• Warning threshold: >4.0% — requires enhanced monitoring
• Risk mechanism: iodine sublimes from capsule → accumulates in primary packaging →
  creates radioactive vapor cloud when opened → personnel inhalation
• Accelerating factors: temperature >25°C, humidity >60%, capsule damage,
  prolonged storage (>30 days)

Key features:
• Stability prediction until end of shelf life (60 days) accounting for storage conditions
• Trend analysis with previous measurements (volatile iodine growth rate)
• Temperature and humidity impact correction
• Risk categorization: LOW / MEDIUM / HIGH / CRITICAL
• Specific action and storage recommendations
• Personnel risk assessment with required protective measures

Prediction model:
• Base growth rate: 0.03%/day at ideal conditions (25°C, <50% humidity)
• Temperature correction: ×1.3 at 25-30°C, ×1.8 at >30°C
• Humidity correction: ×1.2 at >60% humidity
• Prediction = Current value + (Rate × Days until expiry)

Interpretation guide:
• CRITICAL (≥5.0%): Immediately remove from circulation! Quarantine! Investigate!
• HIGH (4.5-4.9% or prediction >5.0%): Use within 7 days or discard
• MEDIUM (4.0-4.4% or trend >0.02%/day): Daily monitoring, verify storage conditions
• LOW (<4.0% and stable trend): Routine monitoring 1x/week

💡 Practical tips:
1. Always measure volatile iodine by sublimation method (not gas chromatography!)
2. Store capsules at 15-25°C and humidity <50% — reduces growth rate by 60%
3. At values >4.0% visually inspect capsule integrity
4. For batches >30 days old increase monitoring frequency to daily
5. Document all measurements for audits — this is a critical safety parameter

⚠️ Limitations:
• Prediction based on simplified model — actual conditions may vary
• Does not account for micro-damaged capsules (requires visual inspection)
• Does not replace official pharmacopoeial analytical method
• For batches with damaged packaging — immediate removal regardless of readings

Data sources:
• USP General Chapter <823> — Radiopharmaceuticals for Positron Emission Tomography
• Ph. Eur. Monograph 2481 — Iodine I 131 Capsules
• IAEA Safety Reports Series No. 63 (2009) — Radiation Protection in Nuclear Medicine
• Journal of Radioanalytical and Nuclear Chemistry — Volatility studies of I-131 capsules (2018)